PCN46 ASSESSING THE QUALITY OF THE EVIDENCE OF NIVOLUMAB ACCORDING TO THE HTA REQUIREMENT IN ARGENTINA

Abstract

Authors

M. Glancszpigel J. Caporale D. Glujovsky P. Valanzasca

Full Text Cite This Article
Back to Volume 19, Supplemental S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×